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(H. Peng).Diabetic nephropathy (DN) is a major diabetic complication. However, the initiating molecular
events triggering DN are unknown. In this study we focused on microRNA-451 (miR-451), which
is downregulated during early DN. We found that miR-451 negatively regulated the expression of
Ywhaz through Ywhaz 30UTR and that Ywhaz was required for the miR-451-mediated downregula-
tion of p38 MAPK signalling. Moreover, over-expression of miR-451 inhibits glomerular mesangial
cell proliferation in vitro and in vivo. These ﬁndings suggest that the growth-inhibitory effect of
miR-451 may be explained in part by miR-451-induced suppression of Ywhaz and p38 MAPK signal-
ling, providing evidence for the potential role of miR-451 in early DN.
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Diabetes is the leading cause of end-stage renal failure, and
much of the morbidity and mortality of diabetes can be attributed
to nephropathy. Diabetic nephropathy (DN) is characterized early
in its course by glomerular hypertrophy and, importantly, mesan-
gial hypertrophy, which is associated with the eventual glomerulo-
sclerosis [1]. Despite the great progresses that have been made in
recent decades, the mechanism involved in mesangial hypertrophy
is not fully understood.
MicroRNAs (miRNAs) are a group of small, non-coding RNAs
that negatively regulate gene expression by imprecisely binding
to complementary sequences in the 30 untranslation region (UTR)
of their target mRNAs. Imperfect base pairing between a miRNA
and its targets suggests that miRNAs have a large regulatory
potential, and miRNAs are estimated to regulate 30% of genes in
the human genome [2]. Recently, it has been reported that miRNAs
play a role in diabetes mellitus and its complications [3]. The
pancreatic islet-speciﬁc miRNA, miR-375, plays a negative role inchemical Societies. Published by E
f Cell Biology and Medical
cal College Road, Chongqing,
ng), penghuimin6@sohu.cominsulin secretion, and it is also a key determinant of blood
homeostasis [4]. The overexpression of miR-29 aggravates insulin
resistance [5]. MiR-133 promotes diabetic cardiopathy by inhibit-
ing kalium ion channel of ERG gene, indicating the participation
of miRNAs in diabetes mellitus and its complications [6]. Moreover,
in our previous studies, we found the deregulation of somemicroR-
NAs was a frequent event in early DN, including microRNA-451
(miR-451) [7]. However, the role of miR-451 in mediating mesan-
gial hypertrophy of DN has never been studied.
In this study, we investigated the potential role of miR-451 in
mesangial hypertrophy during early DN in vitro and in vivo. We
utilized computational and experimental approaches for predic-
tion and veriﬁcation of miR-451 targets. By bioinformatics analy-
sis, we discovered ﬁve potential target genes for miR-451. We
also provided strong experimental evidence that miR-451 nega-
tively regulated the expression of Ywhaz (tyrosine3-monooxy-
genase/tryptophan 5-monooxygenase activation protein, zeta)
through Ywhaz 30UTR. Moreover, our studies conﬁrmed that
over-expression of miR-451 caused the reduction of p38 mito-
gen-activated protein kinase (p38 MAPK) and MAP kinase kinase
3 (MKK3), one of the immediate upstream kinases that regulate
p38 MAPK signaling via the mechanism involving miR-451-med-
iated suppression of Ywhaz. In addition, the growth-inhibitory ef-
fects of miR-451 on the mesangial cells were determined bothlsevier B.V. All rights reserved.
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mediated regulatory pathways are complex and play a critical
role in DN.
2. Materials and methods
2.1. MiR-451 target prediction
MiR-451 target site prediction was performed by using miRGen
software [8]. The intersection of the three algorithms: miRanda
(microrna.org), PicTar, TargetScan, were chosen.
2.2. Constructs, transfections, and assays
Mesangial cells of db/db DN mice (db/db-MC) were transfected
with miR-451 mimics or a mimics control (Guangzhou RuiBio
Corp., Guangzhou, China) [9], using Lipofectamine 2000 (Invitro-
gen, CA, USA), as previously described [10]. Mesangial cells of db/
m mice (db/m-MC) were also transfected with miR-451 inhibitor
or an inhibitor control (Guangzhou RiBo Corp., Guangzhou, China),
where all the nucleotides in the inhibitors contain 20-OMe modiﬁ-
cations at every base. Forty-eight hours after transfection, cells
were harvested for Western blot analysis.
The 30UTR of the Ywhaz genewas ampliﬁed by PCR from the total
RNA extracted from db/db DNmesangial cells, which was extracted
with a Genomic DNA Extraction kit (TaKaRa Bio Inc, Tokyo, Japan).
Primers for Ywhaz 30UTRwere as follows: Ywhaz-F: 50-CCGCTCGAG
CCGGCCTTCCAACCTTTGTC-30; Ywhaz-R: 50-GAATGCGGCCGC-TCC
CATCATCAATATTTATTGAGCATTTAC-30. The PCR products were ex-
cised with XhoI and NotI and cloned into pmiR-RB-REPORT™ vector
(GuangzhouRuiBio Corp., Guangzhou, China). This plasmid contains
ahRluc (syntheticRenilla luciferasegene)encodingRenilla luciferase
as the reporter and hluc (synthetic ﬁreﬂy luciferase gene) encoding
ﬁreﬂy luciferase as the internal control. The recombinant plasmid
pmiR-RB-Ywhaz-30UTRwas conﬁrmed by restriction enzyme diges-
tion and DNA sequencing. A Dual-Luciferase Reporter Assay System
(Promega) was used to examine the effects of miR-451 on Ywhaz
[11] (details shown in Supplementary data).
The expression of miR-451 was induced by injection of the
plasmid into themice.Mmu-miR-451gene sequenceswere selected
from the miRBase at http://microrna.sanger.ac.uk/sequences/. Mir-
451 (mmu-miR-451, MIMAT0001632) was chemically synthesized
(Takara Shuzo, Shiga, Japan), andcontaineda SacI restriction enzyme
cut site: mmu-miR-451-A 50-GATCCCCAAACCGTTACCATTACTGAGT
TTTTTTTGTCGACA-30; mmu-miR-451-B 50-AGCTTGTCGACAAAAAA
AACTCAGTAATGGTAACGGTTTGGG-30. The DNA segments were
cloned into pGenesil-1 expression vectors (Wuhan Genesil Biotech-
nology Co. Ltd, Wuhan, China) and conﬁrmed by DNA sequencing.
2.3. Cell culture
Primary mouse mesangial cells isolated and cultured as de-
scribed previously [12], cultured in RPMI 1640 medium with
5 mmol/l glucose (low glucose) or 25 mmol/l glucose (high
glucose) and 10% fetal bovine serum (FBS).
2.4. Animals
Naturally developed diabetic nephropathy in db/db mice is a
well-established model for type 2 diabetes, obesity, and insulin
resistance. The db/db mice were widely used as diabetic nephrop-
athy model mice because elevated serum creatinine, urinary
albuminuria and proteinuria, increased ﬁbrosis in the proximal
tubule, and mesangial matrix expansion are all reminiscent of
human disease in this model. Obese diabetic C57BL/6JLepr back-ground db/db and heterozygote age-matched db/m mice were
purchased from SLACCAS (Shanghai, China). To avoid a sex-re-
lated discrepancy in the results, only male mice were used. All
animal experiments were conducted in accordance with princi-
ples described in Guidelines by NIH for care and use of experi-
mental animals. Thirty-two 7w-db/db mice were divided into
four groups: control group (8 normal untreated db/m mice),
pGenesil-miR-451-treated db/db group (8 mice), pGenesil-1-trea-
ted db/db group (8 mice) or untreated db/db group (8 mice). Mice
were injected intraperitoneally with plasmids (30 mg/kg/d of
miR-451 or 30 mg/kg/d of pGenesil-1) until albuminuria was de-
tected in the untreated db/db mice (Mice with albuminuria were
regarded as early DN mice [13]). Whole blood was obtained from
the retro-orbital sinus of fed mice, and glucose and UAE were
measured using an automatic biochemistry analyzer (Hitachi,
Ltd., Tokyo, Japan). After mice were killed, cortical sections of
both kidneys from each mouse were pooled. Glomeruli were
isolated by differential sieving. A slice of cortical tissue from each
mouse was also immediately frozen in liquid nitrogen for later
use.
2.5. Real time reverse transcription (RT)-PCR
RNA was extracted by Trizol reagent (Invitrogen). MiR-451
expression in mesangial cells and in db/db mice, were measured
by real time RT-PCR (details shown in Supplementary data).
2.6. Growth inhibition test
MTT Cell Proliferation Assay Kit (Invitrogen) was employed to
analyze cell proliferation (details shown in Supplementary data).
2.7. Glomerular morphological observation
Sieved renal glomeruli taken from mice were observed under
the microscope and measured with a micrometer. The average
diameter of 100 glomeruli in a group was counted in three differ-
ent visual ﬁelds.
2.8. Western blot analysis
Ywhaz, p-p38 MAPK and p-MKK3 proteins were detected by
Western blot using rabbit polyclonal anti-Ywhaz (sc-1019, Santa
Cruz, CA, USA), mouse monoclonal anti-p-p38MAPK (sc-7973,
Santa Cruz, CA, USA) and rabbit polyclonal anti-(p-MKK3)
(sc-293107, Santa Cruz, CA, USA), respectively (details shown in
Supplementary data).
2.9. Immunoﬂuorescence
Expression of Ywhaz and co-expression of p-p38 MAPK and
p-MKK3 proteins in mice were detected by immunoﬂuorescence
(details shown in Supplementary data).
2.10. Statistical analysis
All statistical tests were performed using SPSS software (SPSS,
Chicago, IL). Comparisons between groups were carried out by
ANOVA or Kruskal-Wallis tests, as appropriate, according to the
Gaussian or non-Gaussian distribution of the data. Changes in
each group were analyzed using one-way ANOVA or non-
parametric tests. P-values < 0.05 were considered statistically sig-
niﬁcant. All data are presented as means ± standard deviation
(S.D.).
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3.1. Bioinformatic analysis for miR-451 target prediction
The purpose of computational analysis was to seek potential
targets for mmu-miR-451. miRGen [8], an integrated database,
provides the predicted target groups by using optimized combina-
tions of the widely used target prediction programs. To improve
the accuracy of prediction, we chose the intersection of the three
most widespread programs: miRanda (microrna.org), PicTar,
TargetScan. As a result, we obtained ﬁve possible targets for
miR-451 (Supplementary Table 1).
3.2. Ywhaz 30UTR contains a conserved binding site for mmu-miR-451
Among these predicted candidate targets for miR-451, Ywhaz
attracted our attention due to its roles on cell proliferation at some
pathological conditions [14–16] and its regulation on insulin
receptor signal pathway by interacting with IRS1 protein and
MAPK pathway by effecting on the activation of JNK1 and p38
MAPK, the important signal pathways related to diabetes and DN
[17,18]. Ywhaz (14-3-3 f) belongs to the 14-3-3 family of proteins,
which are a group of highly conserved proteins that are involved in
many vital cellular processes such as metabolism, protein trafﬁck-
ing, signal transduction, apoptosis and cell cycle regulation
[19,20].
By bioinformatics analysis, a 7-nt match (nucleotides 2–8) to
the seed region at the 50 end of mature miR-451 is present in the
Ywhaz 30UTR (Supplementary Fig. 1A), which is considered to be
required for the target recognition [21]. By analyzing homology,
we found that the putative mmu-miR-451 target site in Ywhaz
30UTR is highly conserved in all fourteen genomes, including
human, mouse, rat, horse, monkey, and so on (SupplementaryFig. 1. miR-451 regulates Ywhaz expression via the Ywhaz 30UTR. (A) miR-451 negative
and db/m-MC). Transfection of miR-451 mimics in db/db-MC group (left) caused a signiﬁ
MC group (right) induced a marked increase of Ywhaz protein. (B) Quantiﬁcation of re
expressed as means ± S.D. (n = 3). ⁄⁄P < 0.01 and ⁄P < 0.05 vs. corresponding cells withou
cells. (C) Luciferase activity of various reporters in the presence or absence of miR-451 m
or absence of miR-451 inhibitor in db/m-MC group. The ratio of reporter (Renilla lucifears
normalized to the control value from the control transfection, in which pmiR-RB-REPOR
(D), respectively. All the data plotted as a percentage of the corresponding control valu
corresponding control value.Fig. 1B). Given the analysis stated above, Ywhaz was chosen for
further investigation.
3.3. Ywhaz is a target for miR-451
To verify the targeting of endogenous Ywhaz by miR-451, we
transfected miR-451 mimics or NC mimics into mesangial cells of
db/db DN mice because miR-451 expression was decreased in
the kidney of DN [7]. It showed that the expression of miR-451
was highly increased in miR-451 mimics-transfected db/db DN
cells compared with NC mimics-transfected db/db DN cells (Sup-
plementary Fig. 2A). Western blot for Ywhaz protein showed that
the expression level of Ywhaz was reduced signiﬁcantly in db/db
mesangial cells transfected with miR-451 mimics, compared with
the NC mimics-transfected and non-transfected cells (Fig. 1A and
B). No signiﬁcant differences in the levels of Ywhaz protein were
observed between the cells transfected with the mimics control
and non-transfected cells. Then, we investigated whether Ywhaz
expression is depressed by blocking miR-451 activity in db/m
mesangial cells expressing native miR-451. A similar approach
has been used to study the relationship between let-7 and RAS
[22]. Real-time RT PCR showed that the expression of miR-451
was decreased in miR-451 inhibitor-transfected db/m cells com-
pared with NC inhibitor-transfected db/m cells (Supplementary
Fig. 2B). An approximately 50% increase of Ywhaz protein level
was observed in db/m mesangial cells transfected with miR-451
inhibitor, compared to NC inhibitor-transfected db/m mesangial
cells (Fig. 1A and B). These data indicate that miR-451 can
negatively regulate Ywhaz expression.
Negative regulation of Ywhaz protein levels bymiR-451 could be
explained by the direct interaction betweenmiRNA andmRNA or by
an indirect effect. Given that the 30UTR of Ywhaz contains amiR-451
complementary site,wepropose that this regulation is direct. To testly regulates the expression of Ywhaz in db/db and db/m mesangial cells (db/db-MC
cant reduction of Ywhaz protein, while introduction of miR-451 inhibitor into db/m-
lative levels of Ywhaz protein in db/db-MC (left) and db/m-MC (right). Data were
t treatments, ##P < 0.01 and #P < 0.05 vs. the corresponding NC mimics transfected
imics in db/db-MC group. (D) Luciferase activity of various reporters in the presence
e, Rluc) to control plasmid (Fireﬂy luciferase, Luc) in relative luminescence units was
T and pmiR-RB-Ywhaz-30UTR were cotransfected into db/db-MC (C) and db/m-MC
e. Error bars (S.E.) are derived from nine experiments in triplicate. ⁄P < 0.05 vs. the
Fig. 2. Effect of miR-451 on the expression of Ywhaz, p38 MAPK and MKK3 by Western blot in vitro and in vivo. (A) Representative Western blot analysis showed that the
signiﬁcant decrease of Ywhaz, p38 MAPK and MKK3 proteins in miR-451-transfected cells, compared with NC mimics-transfected cells. (B) Quantiﬁcation of expression data
shown in (A). Data were expressed as means ± S.D. (n = 3). ⁄⁄P < 0.01 and ⁄P < 0.05 vs. untransfected cells, ##P < 0.01 vs. the NC mimics-transfected group. (C) Representative
Western blot analysis showed that the signiﬁcant decrease of Ywhaz, p38 MAPK and MKK3 proteins in the kidneys of miR-451-treated mice, compared with the kidneys of
pGenesil-1-treated mice. (D) Quantiﬁcation of expression data shown in (C). Data were expressed as means ± S.D. (n = 8). ⁄⁄P < 0.01 vs. untransfected cells, ##P < 0.01 vs. the
pGenesil-1-treated group.
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30UTR (Supplementary Fig. 3) and cotransfected db/db mesangial
cells with each of the luciferase/Ywhaz 30UTR reporters combined
with either miR-451 mimics or the mimics control. As shown in
Fig. 1C, transcripts carrying the Ywhaz 30UTR exhibited a signiﬁ-
cantly reduction in luciferase activity in the presence of miR-451.
In contrast, themimics control had no signiﬁcant effect on the lucif-
erase activity (P > 0.05). These ﬁndings suggested that 30UTR of
Ywhaz contained regulatory information, allowing miR-451 to reg-
ulate Ywhaz. In an effort to conﬁrm this, db/mmesangial cells were
cotransfected each of the luciferase/Ywhaz 30UTR reporters along
withmiR-451 inhibitor or the inhibitor control. Fig. 1D showed that
miR-451 inhibitor did restore luciferase activity of Ywhaz 30UTR.
Conversely, the reporter carrying the Ywhaz 30UTRwas only weakly
affected by the inhibitor control (P > 0.05). Our combined results
provide a strong support that 30UTR of Ywhaz is indeed a target of
miR-451 andmiR-451 negatively regulates the expression of Ywhaz
through the Ywhaz 30UTR.
3.4. Over-expression of miR-451 in vitro and in vivo
MiR-451 was over-expressed in db/db DN mesangial cells by
miR-451 mimics transfection and the tissues of the kidney of
db/db DN mice by pGenesil-miR-451 treatment. Real time RT-
PCR displayed that miR-451 was signiﬁcantly enhanced in db/
db-miR-451 mesangial cells compared with NC mimics transfec-
ted cells (P < 0.01, Supplementary Fig. 2A). Also, the expression
of miR-451 was signiﬁcantly increased in the kidney tissues of
pGenesil-miR-451-treated db/db DN group compared to pGene-
sil-1-treated db/db DN group (P < 0.01, Supplementary Fig. 4).
Together, these data demonstrated that miR-451 was over-
expressed in the db/db-miR-451 mesangial cells by transfectionand in the kidney tissues of db/db DN mice injected with pGene-
sil-miR-451.
3.5. Effects of miR-451 on biochemical parameters in vivo
At 7 weeks of age, db/db mice already showed signiﬁcant
hyperglycemia, whereas UAE did not increase compared with db/
m mice. At 9 weeks of age, db/db mice without treatment showed
signiﬁcant elevation of UAE (data were not shown). Thus, 7-week-
old db/db mice exhibited features similar to the human normoal-
buminuric stage, and 9-week-old mice showed features similar
to the human early stage of diabetic nephropathy.
Plasmids containing miR-451 (30 mg/kg/d) were injected into
7-week-old db/db mice for 2 weeks. There were no signiﬁcant dif-
ferences in body weight, blood glucose and UAE among the miR-
451-treated-db/db group, pGennsil-1-treated db/db group and un-
treated db/db group (data were not shown). Therefore, these data
show that there is maybe no effect on body weight, blood glucose
and UAE of db/db mice when over-expressed miR-451 in vivo.
3.6. Growth-inhibitory effect of miR-451 in vitro and in vivo
To determine the role of miR-451 in cell proliferation, we exam-
ined the cell viability by MTT assay. The proliferation of miR-451
mimics-transfected mesangial cells was signiﬁcantly inhibited
compared with untreated db/db mesangial cells and NC mimics-
transfected cells (Supplementary Fig. 5). The result is in agreement
with previous data showing that over-expression of miR-451 sup-
presses cell growth in vitro [23]. Moreover, we evaluated the
growth suppression effect of miR-451 in vivo. The diameter of
glomeruli of 9-week-old mice was signiﬁcantly greater in the
pGenesil-1-treated and untreated db/db groups than that in the
Fig. 3. Immunoﬂuorescence staining of the expression of Ywhaz (red), p-p38 MAPK (green) and p-MKK3 (red) in renal glomerular tissue of db/db DNmice. (A) The expression
of Ywhaz was tested by immunoﬂuorescence staining. Representative photographs were taken from renal tissues of untreated db/db (A1), pGenesil-1-treated db/db (A2),
miR-451-treated db/db (A3) groups and untreated db/m controls (A4). The expression of Ywhaz in renal glomerular tissue of miR-451-treated group was reduced compared
with those in the pGenesil-1-treated and untreated db/db groups. (B) The co-expression of p-p38 MAPK and p-MKK3 in renal glomerular tissue were tested by dual-
ﬂuorescence staining. Merging of both images (yellow) showed co-localization of p-p38 MAPK (green) and p-MKK3 (red) in renal tissues of db/db DN mice. Representative
photographs were taken from renal tissues of untreated db/db (B1), pGenesil-1-treated db/db (B2), miR-451-treated (B3) and the normal control (B4) groups. The expression
of p-p38 MAPK and p-MKK3 were co-decreased in the renal tissues in the miR-451-treated group compared with those in the pGenesil-1-treated and untreated groups.
Arrows indicate renal glomerular tissue. Figures are shown at 400 magniﬁcation.
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group than in the pGenesil-1-treated and untreated groups
(Supplementary Fig. 6). Together, these data conﬁrm that
over-expression of miR-451 inhibits the glomerular mesangial cell
proliferation in vitro and in vivo.
3.7. miR-451 contributes to the restoration of p38 MAPK signaling by
targeting of Ywhaz in vitro
As stated above, we veriﬁed that Ywhaz is a target for miR-451.
Notably, it has been reported that Ywhaz related to cell prolifera-
tion and regulates the insulin receptor signal pathway and p38
MAPK signal pathway [14,17,18], suggesting that Ywhaz maybe
have a relationship with mesangial hypertrophy in early stage of
DN. Therefore, it is tempting to speculate that over-expression of
miR-451 might have an effect on some DN related genes via
down-regulation of Ywhaz.
Moreover, p38 MAPK signaling is known to promote inﬂamma-
tory and proﬁbrotic responses and has been associated with other
cellular functions such as glucose uptake, cell differentiation, apop-
tosis and proliferation [24–26], and highly associated with the glo-
merular mesangial cell proliferation and extracellular matrix
deposition in early period of DN [27]. The expression and activity
of p38MAPK were increased in the kidney tissues of early diabetic
nephropathy rat [28] and were also enhanced in the mesangial cell
cultured with high glucose [29], suggesting that p38MAPK path-
way plays an important role in DN in vitro and vivo.
To test this hypothesis, we examined the protein levels of p38
MAPK signaling: p-p38 MAPK and p-MKK3. A decrease in Ywhaz
and the coordinated reduce in p-p38 MAPK and p-MKK3 were ob-
served in db/db-miR-451 mesangial cells, compared with un-
treated db/db mesangial cells and control db/db mesangial cells,
as tested by Western blot (Fig. 2A and B). Therefore, it indicates
that over-expression of miR-451 in db/db-miR-451 mesangial cells
can decrease the expression of p-p38MAPK and p-MKK3. However,
the exact mechanism of miR-451-mediated depression of p38
MAPK and MKK3 is not fully clear, and further studies are needed
to clarify the issue.
3.8. Effect of miR-451 on Ywhaz and p38 MAPK signaling expression
in vivo
To determine the in vivo relevance of these observations, we
tested the expression of Ywhaz, p-p38 MAPK and p-MKK3 from
the kidney tissue of db/db DN mice. Consistent with results
in vitro, the reductions of Ywhaz, p-p38 MAPK and p-MKK3 level
were detected by Western blot in the kidney tissue of pGenesil-
miR-451-treated db/db mice, when compared with pGenesil-1-
treated db/db mice and untreated db/db mice (Fig. 2C and D).
Immunoﬂuorescence assay revealed that Ywhaz was reduced,
and p-p38 MAPK and p-MKK3 were co-decreased in the kidney tis-
sue of miR-451-treated db/db mice, when compared with pGene-
sil-1-treated db/db mice and untreated db/db mice (Fig. 3 A and
B). Taken together, these in vivo data strong support our in vitro
ﬁndings that miR-451 represses Ywhaz expression and concomi-
tantly reduces the expressions of p-p38 MAPK and p-MKK3 in early
DN.
In conclusion, miR-451 prevented mesangial hypertrophy by
targeting the reduction of Ywhaz and p38 MAPK signaling in vivo
and in vitro. Therefore, miR-451 might play an important role in
the pathogenesis of DN and offers a potential target for interven-
tion and prevention of DN. Further investigations are required,
including a larger number of specimens, and more studies on the
‘‘crosstalk’’ of the network over the deregulated miRNAs in DN
are also needed.Acknowledgments
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